+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Defibrillators Market Report and Forecast 2024-2032

  • PDF Icon

    Report

  • 200 Pages
  • July 2024
  • Region: Global
  • Expert Market Research
  • ID: 5989310
The global defibrillator market size was valued at USD 9.5 billion in 2023. It is expected to grow at a CAGR of 5.10% during the forecast period of 2024-2032, driven by the growing emphasis on public access to defibrillators. The market is experiencing robust growth and is expected to reach USD 14.9 billion by 2032.

Global Defibrillator Market Analysis

Defibrillators are critical medical devices used to restore a normal heartbeat by sending an electric pulse or shock to the heart. They are used to prevent or correct an arrhythmia, a heartbeat that is uneven or that is too slow or too fast. Defibrillators can also restore the heart's beating if the heart suddenly stops. Different types of defibrillators work in different ways. Automated external defibrillators (AEDs), implanted cardioverter-defibrillators (ICDs), and wearable cardioverter defibrillators (WCDs) are some of the common types available in the market.

Market Drivers

  • Rising Incidence of Cardiovascular Diseases: The global increase in cardiovascular diseases (CVDs), including heart failure, arrhythmias, and sudden cardiac arrest, is a major driver for the defibrillator market. Aging populations and changing lifestyle factors such as diet and physical inactivity contribute to the rise in CVDs.
  • Technological Advancements: Innovations in defibrillator technology, such as the development of more sophisticated ICDs and the integration of defibrillators with wireless technology, are improving patient outcomes and expanding the scope of defibrillator applications.
  • Increasing Public Access Initiatives: There's a growing trend of placing AEDs in public places like airports, schools, and offices. This initiative, driven by both governmental and non-governmental organizations, enhances the public's ability to respond to cardiac emergencies.

Challenges

  • High Cost: The high cost of advanced defibrillators and their installation remains a significant barrier, especially in low- and middle-income countries. Additionally, the maintenance and replacement of these devices add to the long-term expenses.
  • Regulatory Hurdles: Stringent regulatory requirements for the approval of medical devices can delay product launches and increase development costs. Compliance with these varying regulations across different regions makes it challenging for manufacturers.
  • Lack of Awareness and Training: There is a critical need for regular training and awareness programs about how to use AEDs effectively. Inadequate training can hinder the optimal use of defibrillators, affecting market growth.

Future Opportunities

  • Emerging Markets: Increasing healthcare expenditure and growing awareness about cardiac arrest treatments in emerging markets present significant opportunities for the expansion of the defibrillator market.
  • Integration with Telemedicine: Linking defibrillator devices with telemedicine platforms offers a promising opportunity to enhance real-time monitoring and support for patients, potentially opening new avenues for market growth.
  • Advancements in Wearable Technology: The development of more compact and user-friendly wearable defibrillators that can be used outside the hospital setting could cater to a broader audience, promoting growth.
  • Government and NGO Initiatives: Increasing initiatives by governments and NGOs to equip public places with AEDs and to conduct training programs can further drive the demand for defibrillators.

Global Defibrillator Market Trends

The global defibrillator market is witnessing several key trends that are shaping its growth and evolution. These trends reflect ongoing technological advancements, regulatory changes, and shifts in healthcare practices globally.
  • Technological Innovation
Innovations in defibrillator technology continue to drive the market. Modern defibrillators are becoming more integrated with other monitoring equipment, enhancing their effectiveness and user-friendliness. For instance, newer models feature improvements in battery life, ease of use, and software that can analyze a patient's heart rhythm more accurately. Furthermore, the incorporation of AI and machine learning to guide rescuers in performing CPR and using the device during a cardiac emergency is becoming more prevalent.
  • Increased Public Access and Training
There is a growing emphasis on public access to defibrillators (PAD), especially automated external defibrillators (AEDs), in public places such as schools, airports, and sports arenas. This trend is accompanied by increased community and workplace training initiatives, ensuring that more people are equipped to use these devices in emergencies. Governments and health organizations are also launching campaigns to educate the public about the importance of early defibrillation.
  • Wearable Defibrillator Growth
Wearable cardioverter defibrillators (WCDs) are gaining traction as they provide continuous protection for at-risk patients outside of the hospital. These devices are particularly useful for patients who are not immediate candidates for an implantable device or are undergoing medical evaluations. The market for WCDs is expanding, driven by their non-invasive nature and the growing awareness of sudden cardiac arrest risks.
  • Integration with Telehealth Services
The integration of defibrillators with telehealth platforms is a significant trend. These integrations allow for real-time data monitoring and analysis by healthcare professionals, improving patient outcomes after cardiac events. Such connectivity ensures ongoing patient monitoring and immediate professional intervention when abnormalities are detected.
  • Regulatory and Reimbursement Landscape Changes
Changes in the regulatory and reimbursement landscape are also affecting the defibrillator market. For instance, regulatory bodies in various regions are implementing more stringent guidelines on the manufacture and use of defibrillators. At the same time, there are efforts to improve reimbursement scenarios for advanced defibrillators, which could increase their adoption, particularly in cost-sensitive markets.
  • Expansion in Emerging Markets
Emerging markets are increasingly contributing to the growth of the global defibrillator market. Factors such as improving healthcare infrastructure, rising healthcare spending, and the growing prevalence of cardiovascular diseases are propelling demand in these regions. Manufacturers are targeting these areas with cost-effective solutions and are expanding their distribution networks to capture growth opportunities.
  • Focus on Compact and Mobile Solutions
The trend towards making defibrillators more compact and mobile continues as users demand devices that are easy to carry and deploy. This is especially important for first responders and in-home care settings where portability can make a significant difference in emergency responsiveness.

Global Defibrillator Market Segmentation

Market Breakup by Product

  • Implantable Cardioverter Defibrillator
  • Subcutaneous ICD
  • External Defibrillator
The global defibrillator market is segmented into implantable cardioverter defibrillators (ICDs), subcutaneous ICDs, and external defibrillators, each poised for significant growth due to increasing cardiovascular disease prevalence and technological advancements. Implantable cardioverter defibrillators are vital for continuous internal monitoring and treatment of arrhythmias, driving their demand particularly in high-risk patient groups. Subcutaneous ICDs, benefiting from less invasive installation and reduced complications, are becoming more popular, offering substantial growth opportunities. External defibrillators, essential in public and emergency settings due to rising public health initiatives for widespread AED deployment, are expected to expand notably. Collectively, these segments are set to substantially drive the market growth during the forecast period due to their critical roles in cardiac emergency management and prevention.

Market Breakup by Patient Type

  • Adult
  • Pediatric
The defibrillator market is divided into two key patient segments: adult and pediatric, each with distinct growth trajectories and market drivers. Adult defibrillators dominate due to the higher prevalence of cardiovascular diseases among adults, particularly in aging populations globally. This segment benefits from widespread usage in public places and medical facilities, driven by increased health awareness and public access initiatives. On the other hand, the pediatric segment, although smaller, is witnessing growing attention due to the rising awareness of congenital heart diseases and the specific needs for appropriate cardiac arrest interventions in children. Technological advancements in pediatric-specific defibrillators are expected to further drive growth in this segment. Overall, both segments are crucial to the expansion of the global defibrillator market, with adult defibrillators leading in volume while pediatric defibrillators grow in specialized applications.

Market Breakup by End User

  • Hospitals
  • Prehospital
  • Home care
  • Public Access
The defibrillator market is segmented by end-users into hospitals, prehospital, home care, and public access areas, each contributing uniquely to market growth. Hospitals are the largest segment, driven by the increasing installation of both implantable and external defibrillators for acute patient care and the rising incidence of cardiovascular diseases requiring advanced medical facilities. The prehospital segment is growing due to enhancements in emergency medical services (EMS) and the integration of advanced defibrillators in ambulances. Home care is expanding as technological advancements make defibrillators more user-friendly, encouraging their use in home settings for high-risk patients. Lastly, the public access segment is poised for significant growth, spurred by global initiatives to install Automated External Defibrillators (AEDs) in public places like schools, sports arenas, and transportation hubs to improve response times during cardiac emergencies. Each segment's expansion is critical to the overall market growth, addressing specific needs and environments to enhance cardiac care accessibility and effectiveness.

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
The defibrillator market is segmented geographically into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa, each displaying unique growth dynamics and potential. North America leads the market, driven by advanced healthcare infrastructure, high healthcare expenditure, and robust public health initiatives promoting the use of AEDs in public and private spaces. Europe follows closely, with stringent healthcare regulations and a strong emphasis on cardiac safety propelling the adoption of advanced defibrillators.

The Asia Pacific region presents significant growth opportunities, fueled by increasing healthcare awareness, rising incidences of cardiovascular diseases, and improving healthcare facilities in emerging economies such as China and India. Latin America and the Middle East and Africa are experiencing growth due to expanding healthcare systems and increasing medical tourism, though challenges such as cost constraints and lack of awareness persist.

Global Defibrillator Market Competitive Landscape

The competitive landscape of the global defibrillator market is characterized by the presence of several major players and a range of dynamic market activities aimed at enhancing market position and addressing evolving medical needs. Key players in the market include Medtronic, Stryker, Koninklijke Philips N.V., Asahi Kasei Corporation, Boston Scientific Corporation, NIHON KOHDEN CORPORATION, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Biotronik, MicroPort Scientific Corporation, Abbott, HeartSine Technologies, Ltd., ZOLL Medical Corporation, SCHILLER, and LivaNova PLC. These companies are actively engaged in mergers and acquisitions, forming strategic partnerships, launching new products, and investing in research initiatives to innovate and expand their product offerings. These activities not only enhance their capabilities but also allow them to enter new markets and increase their market share, thereby maintaining competitiveness in a rapidly evolving industry.

Key Questions Answered in the Report

  • What is the current and future performance of the defibrillator market?
  • What are the main challenges facing the defibrillator market?
  • What are the key drivers of the defibrillator market?
  • What emerging trends are shaping the future of the defibrillator market?
  • How do hospitals contribute to the growth of the defibrillator market?
  • What factors are driving the expanding market for wearable cardioverter defibrillators (WCDs)?
  • How are innovations in defibrillator technology improving patient outcomes and expanding their applications?
  • Why is there a growing emphasis on public access to defibrillators in public places?
  • Why are subcutaneous ICDs becoming more popular in the treatment of arrhythmias?
  • How do telemedicine platforms enhance the functionality of defibrillator devices?
  • What are the common strategies used by key players in the defibrillator market?

Key Benefits for Stakeholders

  • The industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the global defibrillator market from 2017-2032.
  • The research report provides the latest information on the market drivers, challenges, and opportunities in the defibrillator market.
  • The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
  • Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the defibrillator industry and its attractiveness.
  • The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.


This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Defibrillator Market Overview
3.1 Global Defibrillator Market Historical Value (2017-2023)
3.2 Global Defibrillator Market Forecast Value (2024-2032)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Defibrillator Market Landscape*
5.1 Global Defibrillator Market: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Defibrillator Market: Product Landscape
5.2.1 Analysis by Product
5.2.2 Analysis by Patient Type
6 Global Defibrillator Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Defibrillator Market Segmentation (2017-2032)
7.1 Global Defibrillator Market (2017-2032) by Product
7.1.1 Market Overview
7.1.2 Implantable Cardioverter Defibrillator
7.1.3 Subcutaneous ICD
7.1.4 External Defibrillator
7.2 Global Defibrillator Market (2017-2032) by Patient
7.2.1 Market Overview
7.2.2 Adult
7.2.3 Pediatric
7.3 Global Defibrillator Market (2017-2032) by End User
7.3.1 Market Overview
7.3.2 Hospitals
7.3.3 Specialty Clinics
7.3.4 Home Care Settings
7.3.5 Others
7.4 Global Defibrillator Market (2017-2032) by Region
7.4.1 Market Overview
7.4.2 North America
7.4.3 Europe
7.4.4 Asia Pacific
7.4.5 Latin America
7.4.6 Middle East and Africa
8 North America Defibrillator Market (2017-2032)
8.1 North America Defibrillator Market (2017-2032) by Product
8.1.1 Market Overview
8.1.2 Implantable Cardioverter Defibrillator
8.1.3 Subcutaneous ICD
8.1.4 External Defibrillator
8.2 North America Defibrillator Market (2017-2032) by Patient
8.2.1 Market Overview
8.2.2 Adult
8.2.3 Pediatric
8.3 North America Defibrillator Market (2017-2032) by End User
8.3.1 Market Overview
8.3.2 Hospitals
8.3.3 Specialty Clinics
8.3.4 Home Care Settings
8.3.5 Others
8.4 North America Defibrillator Market (2017-2032) by Country
8.4.1 United States of America
8.4.2 Canada
9 Europe Defibrillator Market (2017-2032)
9.1 Europe Defibrillator Market (2017-2032) by Product
9.1.1 Market Overview
9.1.2 Implantable Cardioverter Defibrillator
9.1.3 Subcutaneous ICD
9.1.4 External Defibrillator
9.2 Europe Defibrillator Market (2017-2032) by Patient
9.2.1 Market Overview
9.2.2 Adult
9.2.3 Pediatric
9.3 Europe Defibrillator Market (2017-2032) by End User
9.3.1 Market Overview
9.3.2 Hospitals
9.3.3 Specialty Clinics
9.3.4 Home Care Settings
9.3.5 Others
9.4 Europe Defibrillator Market (2017-2032) by Country
9.4.1 United Kingdom
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Others
10 Asia Pacific Defibrillator Market (2017-2032)
10.1 Asia Pacific Defibrillator Market (2017-2032) by Product
10.1.1 Market Overview
10.1.2 Implantable Cardioverter Defibrillator
10.1.3 Subcutaneous ICD
10.1.4 External Defibrillator
10.2 Asia Pacific Defibrillator Market (2017-2032) by Patient
10.2.1 Market Overview
10.2.2 Adult
10.2.3 Pediatric
10.3 Asia Pacific Defibrillator Market (2017-2032) by End User
10.3.1 Market Overview
10.3.2 Hospitals
10.3.3 Specialty Clinics
10.3.4 Home Care Settings
10.3.5 Others
10.4 Asia Pacific Defibrillator Market (2017-2032) by Country
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 ASEAN
10.4.5 Australia
10.4.6 Others
11 Latin America Defibrillator Market (2017-2032)
11.1 Latin America Defibrillator Market (2017-2032) by Product
11.1.1 Market Overview
11.1.2 Implantable Cardioverter Defibrillator
11.1.3 Subcutaneous ICD
11.1.4 External Defibrillator
11.2 Latin America Defibrillator Market (2017-2032) by Patient
11.2.1 Market Overview
11.2.2 Adult
11.2.3 Pediatric
11.3 Latin America Defibrillator Market (2017-2032) by End User
11.3.1 Market Overview
11.3.2 Hospitals
11.3.3 Specialty Clinics
11.3.4 Home Care Settings
11.3.5 Others
11.4 Latin America Defibrillator Market (2017-2032) by Country
11.4.1 Brazil
11.4.2 Argentina
11.4.3 Mexico
11.4.4 Others
12 Middle East and Africa Defibrillator Market (2017-2032)
12.1 Middle East and Africa Defibrillator Market (2017-2032) by Product
12.1.1 Market Overview
12.1.2 Implantable Cardioverter Defibrillator
12.1.3 Subcutaneous ICD
12.1.4 External Defibrillator
12.2 Middle East and Africa Defibrillator Market (2017-2032) by Patient
12.2.1 Market Overview
12.2.2 Adult
12.2.3 Pediatric
12.3 Middle East and Africa Defibrillator Market (2017-2032) by End User
12.3.1 Market Overview
12.3.2 Hospitals
12.3.3 Specialty Clinics
12.3.4 Home Care Settings
12.3.5 Others
12.4 Middle East and Africa Defibrillator Market (2017-2032) by Country
12.4.1 Saudi Arabia
12.4.2 United Arab Emirates
12.4.3 Nigeria
12.4.4 South Africa
12.4.5 Others
13 Regulatory Framework
13.1 Regulatory Overview
13.2 US FDA
13.3 EU EMA
13.4 INDIA CDSCO
13.5 JAPAN PMDA
13.6 Others
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Patent Analysis
15.1 Analysis by Type of Patent
15.2 Analysis by Publication Year
15.3 Analysis by Issuing Authority
15.4 Analysis by Patent Age
15.5 Analysis by CPC Analysis
15.6 Analysis by Patent Valuation
15.7 Analysis by Key Players
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Strategic Initiatives
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 Market Share Analysis, By Region (Top 5 Companies)
18.1.1 Market Share Analysis: Global
18.1.2 Market Share Analysis: North America
18.1.3 Market Share Analysis: Europe
18.1.4 Market Share Analysis: Asia Pacific
18.1.5 Market Share Analysis: Others
18.2 Medtronic PLC .
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Company News and Development
18.2.5 Certifications
18.3 Stryker Corporation
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Company News and Development
18.3.5 Certifications
18.4 Koninklijke Philips N.V .
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Company News and Development
18.4.5 Certifications
18.5 Boston Scientific Corporation
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Company News and Development
18.5.5 Certifications
18.6 Nihon Kohden Corporation
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Company News and Development
18.6.5 Certifications
18.7 Shenzhen Mindray Bio-Medical Electronics Co., Ltd .
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Company News and Development
18.7.5 Certifications
18.8 Biotronik Medical Devices India Pvt. Ltd .
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Company News and Development
18.8.5 Certifications
18.9 MicroPort Scientific Corporation
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic
18.9.4 Company News and Development
18.9.5 Certifications
18.10 Schiller Healthcare India Pvt .
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Company News and Development
18.10.5 Certifications
19 Global Defibrillator Market - Distribution Model (Additional Insight)
19.1 Overview
19.2 Potential Distributors
19.3 Key Parameters for Distribution Partner Assessment
20 Key Opinion Leaders (KOL) Insights (Additional Insight)
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The research team strives to make this section as comprehensive as possible.
**The supplier list is not exhaustive. Moreover, we can provide analysis of companies as per custom requests.

Companies Mentioned

  • Medtronic PLC
  • Stryker Corporation
  • Koninklijke Philips N.V .
  • Boston Scientific Corporation
  • Nihon Kohden Corporation
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd .
  • Biotronik Medical Devices India Pvt. Ltd .
  • MicroPort Scientific Corporation
  • Schiller Healthcare India Pvt .

Methodology

Loading
LOADING...

Table Information